Paolo Tarantino and Laura Huppert/X
Apr 20, 2025, 19:21
Should we sequence ADCs? – Paolo Tarantino vs. Laura Huppert at the Breast Cancer Focus Meeting
Paolo Tarantino, Clinical Research Fellow at the Dana-Farber Cancer Institute, shared a post on X:
“Should we sequence ADCs?
Getting ready for a fierce debate at next week’s Breast Cancer Focus Meeting in Boston, chaired by Sara Tolaney and Virginia Kaklamani.
Challenging me, the undefeated champion Laura Huppert, supporting the NO SEQUENCING position.
Let’s get ready to rumble!”
Learn more about ADCs in cancer on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 16, 2025, 20:13
Jul 16, 2025, 17:55
Jul 16, 2025, 17:38
Jul 16, 2025, 17:37
Jul 16, 2025, 17:04
Jul 16, 2025, 16:51
Jul 16, 2025, 16:34